KU Leuven — Publications

Discovery of novel 1,2,4‐triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein

Article

Abstract Human immunodeficiency virus (HIV) capsid (CA) protein is a promising target for developing novel anti‐HIV drugs. Starting from highly anticipated CA inhibitors PF‐74 , we used scaffold hopping strategy to design a series of novel 1,2,4‐triazole phenylalanine derivatives by targeting an unexplored region composed of residues 106–109 in HIV‐1 CA hexamer. Compound d19 displayed excellent antiretroviral potency against HIV‐1 and HIV‐2 strains with EC 50 values of 0.59 and 2.69 µM, respectively. Additionally, we show via surface plasmon resonance (SPR) spectrometry that d19 preferentially interacts with the hexameric form of CA, with a significantly improved hexamer/monomer specificity ratio (ratio = 59) than PF‐74 (ratio = 21). Moreover, we show via SPR that d19 competes with CPSF‐6 for binding to CA hexamers with IC 50 value of 33.4 nM. Like PF‐74 , d19 inhibits the replication of HIV‐1 NL4.3 pseudo typed virus in both early and late stages. In addition, molecular docking and molecular dynamics simulations provide binding mode information of d19 to HIV‐1 CA and rationale for improved affinity and potency over PF‐74 . Overall, the lead compound d19 displays a distinct chemotype form PF‐74 , improved CA affinity, and anti‐HIV potency.

Xiangyi Jiang, Prem Prakash Sharma, Brijesh Rathi et al. 2022

Publications

Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors

2',3'-Dideoxynucleoside analogues as anti-HIV agents

Thiosugars. Part 12. Synthesis of New 3′‐O‐Substituted 2′,5′‐Anhydro‐2′‐thio‐α‐D‐pentofuranosyl Nucleoside Analogues.

Perspectives for the chemotherapy of AIDS.

Example of data mining use to follow indicators in clinical pathways

A TSP-based algorithm for the bend sequencing problem

Studies on anti-HIV activity of Indigofera tinctoria

Potent Nonclassical Nucleoside Antiviral Drugs Based on the <i>N</i>,<i>N</i>-Diarylformamidine Concept

Methods in Anti-HCMV Research

Antiviral, antimetabolic and antineoplastic activities of 2′-or 3′-amino or -azido-substituted deoxyribonucleosides

Synthesis of Acycloalkenyl Derivatives of Pyrimidines and Purines

Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors

Antiviral Activity of Nucleoside Analogues: The BVDU Connection

ChemInform Abstract: Synthesis and Antiviral Activity of 3′‐Heterocyclic Substituted 3′‐Deoxythymidines.

Setting up a common architecture for EPR in primary care: The Belgian experience

AntiHIV, antibacterial and antifungal activities of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones

NSAID hydroxamic acids: Synthesis, cytostatic and antiviral activity evaluations

In Vivo Antiviral Activity of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine and its Cyclic Form

Discovery of novel 1,2,4‐triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein

CCDC 177527: Experimental Crystal Structure Determination